Annual Shareholders Equity
$150.87 M
+$51.43 M+51.73%
December 31, 2023
Summary
- As of February 7, 2025, TCRX annual stockholders equity is $150.87 million, with the most recent change of +$51.43 million (+51.73%) on December 31, 2023.
- During the last 3 years, TCRX annual shareholders equity has risen by +$193.33 million (+455.30%).
- TCRX annual shareholders equity is now -6.16% below its all-time high of $160.78 million, reached on December 31, 2021.
Performance
TCRX Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Shareholders Equity
$229.09 M
-$26.13 M-10.24%
September 30, 2024
Summary
- As of February 7, 2025, TCRX quarterly stockholders equity is $229.09 million, with the most recent change of -$26.13 million (-10.24%) on September 30, 2024.
- Over the past year, TCRX quarterly shareholders equity has increased by +$60.13 million (+35.59%).
- TCRX quarterly shareholders equity is now -10.24% below its all-time high of $255.22 million, reached on June 30, 2024.
Performance
TCRX Quarterly Shareholders Equity Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Shareholders Equity Formula
Shareholders Equity = Total Assets − Total Liabilities
TCRX Shareholders Equity Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +51.7% | +35.6% |
| 3 y3 years | +455.3% | +35.6% |
| 5 y5 years | +980.3% | +35.6% |
TCRX Shareholders Equity Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -6.2% | +51.7% | -10.2% | +193.6% |
| 5 y | 5-year | -6.2% | +455.3% | -10.2% | +481.6% |
| alltime | all time | -6.2% | +455.3% | -10.2% | +481.6% |
TScan Therapeutics Shareholders Equity History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $229.09 M(-10.2%) |
| Jun 2024 | - | $255.22 M(+107.6%) |
| Mar 2024 | - | $122.97 M(-18.5%) |
| Dec 2023 | $150.87 M(+51.7%) | $150.87 M(-10.7%) |
| Sep 2023 | - | $168.96 M(-11.4%) |
| Jun 2023 | - | $190.61 M(+144.3%) |
| Mar 2023 | - | $78.02 M(-21.5%) |
| Dec 2022 | $99.43 M | $99.43 M(-14.8%) |
| Sep 2022 | - | $116.66 M(-11.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $131.65 M(-9.6%) |
| Mar 2022 | - | $145.69 M(-9.4%) |
| Dec 2021 | $160.78 M(-478.6%) | $160.78 M(-7.6%) |
| Sep 2021 | - | $174.07 M(-390.0%) |
| Jun 2021 | - | -$60.03 M(+20.2%) |
| Mar 2021 | - | -$49.92 M(+17.6%) |
| Dec 2020 | -$42.46 M(+147.8%) | - |
| Dec 2020 | - | -$42.46 M |
| Dec 2019 | -$17.14 M | - |
FAQ
- What is TScan Therapeutics annual stockholders equity?
- What is the all time high annual shareholders equity for TScan Therapeutics?
- What is TScan Therapeutics annual shareholders equity year-on-year change?
- What is TScan Therapeutics quarterly stockholders equity?
- What is the all time high quarterly shareholders equity for TScan Therapeutics?
- What is TScan Therapeutics quarterly shareholders equity year-on-year change?
What is TScan Therapeutics annual stockholders equity?
The current annual shareholders equity of TCRX is $150.87 M
What is the all time high annual shareholders equity for TScan Therapeutics?
TScan Therapeutics all-time high annual stockholders equity is $160.78 M
What is TScan Therapeutics annual shareholders equity year-on-year change?
Over the past year, TCRX annual stockholders equity has changed by +$51.43 M (+51.73%)
What is TScan Therapeutics quarterly stockholders equity?
The current quarterly shareholders equity of TCRX is $229.09 M
What is the all time high quarterly shareholders equity for TScan Therapeutics?
TScan Therapeutics all-time high quarterly stockholders equity is $255.22 M
What is TScan Therapeutics quarterly shareholders equity year-on-year change?
Over the past year, TCRX quarterly stockholders equity has changed by +$60.13 M (+35.59%)